Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1046494-86-3

Post Buying Request

1046494-86-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1046494-86-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1046494-86-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,4,6,4,9 and 4 respectively; the second part has 2 digits, 8 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1046494-86:
(9*1)+(8*0)+(7*4)+(6*6)+(5*4)+(4*9)+(3*4)+(2*8)+(1*6)=163
163 % 10 = 3
So 1046494-86-3 is a valid CAS Registry Number.

1046494-86-3Relevant articles and documents

Synthesis and pharmacological evaluation of bivalent antagonists of the nociceptin opioid receptor

Del Giudice, Maria Rosaria,Borioni, Anna,Bastanzio, Giuditta,Sbraccia, Maria,Mustazza, Carlo,Sestili, Isabella

experimental part, p. 1207 - 1221 (2011/04/23)

Bivalent ligands constituted by two identical pharmacophores structurally related to the Nociceptin Opioid Receptor (NOPr) antagonist JTC-801 were synthesized and their binding affinities for NOPr were evaluated. The novel ligands are formed by two modifi

Dibenzoxepinone hydroxylamines and hydroxamic acids: Dual inhibitors of cyclooxygenase and 5-lipoxygenase with potent topical antiinflammatory activity

Hamer, R. Richard L.,Tegeler, John J.,Kurtz, Ellen S.,Allen, Richard C.,Bailey, Steven C.,Elliott, Mary Ellen,Hellyer, Luther,Helsley, Grover C.,Przekop, Penelope,Freed, Brian S.,White, John,Martin, Lawrence L.

, p. 246 - 252 (2007/10/03)

Hydroxylamine and hydroxamic acid derivatives of a known nonsteroidal antiinflammatory dibenzoxepine series display both cyclooxygenase (CO) and 5- lipoxygenase (5-LO) inhibitory properties. Many of these new dual CO/5-LO inhibitors also exhibit potent topical antiinflammatory activity in the arachidonic acid-induced murine ear edema model. On the basis of their promising profile of in vitro and in vivo activities, hydroxamic acids 24h, 3-(6,11-dihydro-11-oxodibenz[b,e]oxepin-2-yl)-N-hydroxy-N-methylpropanamide (HP 977), and 25, 3-(6,11-dihydrodibenz[b,e]oxepin-2-yl)-N-hydroxy-N- methylpropanamide (P10294), were selected as developmental candidates for the topical treatment of inflammatory skin disorders.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1046494-86-3